SectorBiological Technology
Established Date--
Listing Date27/07/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees38
Fiscal Year Ends31/12
Security TypeCommon stock
Office address117 Kendrick St Suite 450, Needham, MA 02494
Business
IntroductionCandel Therapeutics, Inc., was incorporated in Delaware in June 2003. The company is a clinical-stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that trigger individualized, systemic anti-tumor immune responses to help patients fight cancer.